iopromide
Sign in to saveAlso known as Ultravist 150, Ultravist 240, Ultravist 370, ZK-35760, Ultravist, Ultravist 300, N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide
Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.
Research
2,046 papers- Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.Journal of healthcare engineering · 2022
- [Iopromide-Induced Encephalopathy: A Case Report and Literature Review].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
- Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.Medicine · 2018
- Iopromide safety assessment in a radiology department: A seven-year retrospective characterization of adverse events.The International journal of risk & safety in medicine · 2024
- Pharmacochemical profile of iopromide.AJNR. American journal of neuroradiology · 1983
via PubMed
Wikidata facts
- Mass
- 790.87
Show 3 more facts
- chemical formula
- C₁₈H₂₄I₃N₃O₈
- canonical SMILES
- CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I
- World Health Organisation international non-proprietary name
- iopromide
via Wikidata · CC0
~1 min read
Article
4 sectionsContents
- Medical uses
- Contraindications
- References
- External links
Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.
It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).
Available in 8 languages
via Wikidata sitelinks · CC0